Merck & Co. Inc. (MRK)
NYSE: MRK
· Real-Time Price · USD
80.88
-0.83 (-1.02%)
At close: Jun 16, 2025, 3:59 PM
80.83
-0.06%
After-hours: Jun 16, 2025, 07:59 PM EDT
Merck & Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 30, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Animal Health segment Revenue | 5.88B | 53.58B | 5.55B | 5.57B | 4.7B | 4.39B | 4.21B | 35.39B | 35.15B | 34.78B | 36.04B | 37.44B | 40.6B | 41.29B |
| Animal Health segment Revenue Growth | n/a | n/a | -0.32% | +18.39% | +7.06% | +4.30% | -88.10% | +0.68% | +1.06% | -3.50% | -3.73% | -7.79% | -1.67% | n/a |
| Pharmaceutical segment Revenue | 57.4B | 5.63B | 52.01B | 42.75B | 43.02B | 41.75B | 37.69B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pharmaceutical segment Revenue Growth | n/a | n/a | +21.64% | -0.62% | +3.04% | +10.78% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 30, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 11.83B | 3.23B | 12.43B | 9.51B | 9.86B | 9.73B | 8.3B | 17.42B | 6.76B | 6.49B | 7.42B | 7.89B | 20.39B | 20.5B | 20.23B |
| Asia Pacific Revenue Growth | +266.88% | -74.06% | +30.73% | -3.58% | +1.35% | +17.19% | -52.34% | +157.60% | +4.17% | -12.52% | -5.92% | -61.31% | -0.50% | +1.33% | n/a |
| Emea Revenue | 14.04B | 3.09B | 14.49B | 13.34B | 13.6B | 12.71B | 12.21B | 7.46B | 10.95B | 10.68B | 13.17B | 13.14B | 12.99B | 4.83B | 13.5B |
| Emea Revenue Growth | +354.99% | -78.71% | +8.64% | -1.90% | +7.03% | +4.04% | +63.74% | -31.90% | +2.58% | -18.95% | +0.26% | +1.15% | +168.67% | -64.18% | n/a |
| Latin America Revenue | 3.46B | n/a | 2.58B | 2.21B | 2.27B | 2.47B | 2.42B | 11.48B | 2.15B | 2.82B | 3.15B | 3.2B | 5.1B | n/a | 3.77B |
| Latin America Revenue Growth | n/a | n/a | +17.04% | -2.99% | -7.90% | +2.24% | -78.96% | +432.62% | -23.66% | -10.41% | -1.62% | -37.22% | n/a | n/a | n/a |
| United States Revenue | 32.28B | n/a | 27.21B | 22.43B | 21.03B | 20.32B | 18.21B | 2.34B | 18.48B | 17.52B | 17.07B | 18.25B | n/a | n/a | n/a |
| United States Revenue Growth | n/a | n/a | +21.32% | +6.65% | +3.45% | +11.60% | +678.62% | -87.34% | +5.47% | +2.62% | -6.44% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.55B | 3.3B | 2.73B | 2.74B | 2.48B | 2.8B | 2.52B | 2.7B | 2.48B | 2.69B | 2.52B | 2.51B | 2.32B | 2.83B | 2.34B | 2.28B | 2.19B | 3.08B | 2.06B | 2.08B | 2.56B | 2.89B | 2.59B | 2.71B | 2.42B | 2.64B | 2.44B | 2.51B | 2.51B | 2.58B | 2.46B | 2.5B | 2.47B | 2.59B | 2.39B | 2.46B | 2.32B | 2.62B | 2.47B | 2.62B | 2.6B |
| Selling, General, and Administrative Revenue Growth | -22.57% | +20.69% | -0.29% | +10.31% | -11.45% | +11.31% | -6.77% | +9.00% | -7.74% | +6.63% | +0.32% | +8.14% | -17.92% | +21.15% | +2.41% | +4.30% | -29.11% | +49.76% | -1.20% | -18.40% | -11.56% | +11.59% | -4.54% | +11.84% | -8.25% | +8.19% | -2.59% | 0.00% | -2.75% | +4.88% | -1.64% | +1.13% | -4.67% | +8.36% | -2.64% | +6.04% | -11.36% | +5.78% | -5.79% | +0.88% | n/a |
| Research and Development Revenue | 3.62B | 4.58B | 5.86B | 3.5B | 3.99B | 9.63B | 3.31B | 13.32B | 4.28B | 3.77B | 4.4B | 2.8B | 2.58B | 3.07B | 2.44B | 4.32B | 2.41B | 5.84B | 3.35B | 2.08B | 2.21B | 2.55B | 3.2B | 2.19B | 1.93B | 2.21B | 2.07B | 2.27B | 3.2B | 2.28B | 4.41B | 1.78B | 1.83B | 4.65B | 1.66B | 2.15B | 1.66B | 1.8B | 1.5B | 1.67B | 1.74B |
| Research and Development Revenue Growth | -21.01% | -21.80% | +67.49% | -12.32% | -58.53% | +191.11% | -75.17% | +211.53% | +13.27% | -14.19% | +57.22% | +8.62% | -16.04% | +25.48% | -43.42% | +79.15% | -58.68% | +74.29% | +60.62% | -5.61% | -13.30% | -20.47% | +46.37% | +13.36% | -12.78% | +7.06% | -9.06% | -28.85% | +40.11% | -48.31% | +147.64% | -2.62% | -60.64% | +179.39% | -22.64% | +29.66% | -7.73% | +19.87% | -10.18% | -3.86% | n/a |